Every article in our archive tagged Pen Testing.
Looking for a quick answer instead? The FDA medical device cybersecurity FAQ covers Section 524B scope, SBOMs, threat models, CR515 and GMLP, deficiencies, and postmarket duties.
Showing 5 of 5 articles tagged Pen Testing
What the FDA expects from infusion pump cybersecurity submissions in 2026: threat model focus areas, Section 524B evidence, and the deficiencies reviewers cite.
Read article
When penetration test reports are vague, incomplete, or written to enterprise IT standards rather than medical device requirements, FDA reviewers issue.
Read article
Ensure medical device safety with robustness and fuzz testing. Uncover critical vulnerabilities and maintain performance under diverse conditions.
Read article
How to scope a medical device penetration test the FDA will accept: interfaces to include, what to provide the tester, and why a narrow scope costs review time.
Read article
Medical device penetration testing post exploitation covers pivoting, persistence, exfiltration paths, safety controls, and report evidence reviewers expect.
Read article30-minute strategy session. No cost, no commitment - just answers from people who've shipped 275+ FDA submissions.
